Company Data
Tempest Therapeutics Inc.
Ticker
TPST
Current Price
$3.2 -23.26%
Market Cap
$14.2M
Price Target
Refer to Report
Volume
684.5K
52wk Range
$3.2987 - $13.65
Overview
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.